Last reviewed · How we verify
NCT05254873
Long-term Follow-up of Patients Included in the EYE-TAR(MA) Study.
trial testing Long term follow-up in Alzheimer's Dementia (AD) in 7 participants. Completed in 11 April 2022.
11 April 2022
Quick facts
| Lead sponsor | Association de Recherche Bibliographique pour les Neurosciences |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 7 |
| Start date | 21 January 2022 |
| Primary completion | 11 April 2022 |
| Estimated completion | 11 April 2022 |
| Sites | 1 location across Monaco |
Drugs / interventions tested
- Long term follow-up — full drug profile →
Conditions studied
- Alzheimer's Dementia (AD) — all drugs for Alzheimer's Dementia (AD) →
- Family Caregivers — all drugs for Family Caregivers →
Sponsor
Association de Recherche Bibliographique pour les Neurosciences
Who can join
18 and older, any sex, with Alzheimer's Dementia (AD) or Family Caregivers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
EYE-TAR(MA)-Follow-Up is a non-interventionel, long-term follow-up study in subjects who participated to the study referred as EYE-TAR(MA) (NCT04730440) EYE-TAR(MA)-Follow-Up aims to evaluate the long-term impacts of the Training of Affect Recognition TAR (an emotion recognition rehabilitation program), on social cognition abilities, evolve gaze strategies, behavioral disorders, and the caregiver's burden in Alzheimer's disease (AD). Subjects who completed EYE-TAR(MA) study, and who have signed informed consent for this follow-up, will be eligible to enroll. They will attend one visit two years post EYE-TAR(MA) study intervention (intervention was TAR, or a "classic" cognitive stimulation program) to undergo the following evaluation: Eye-tracking recording during Ekman Faces task, Mini Mental State Examination (MMSE), Neuropsychiatric Inventory (NPI), Zarit scale (completed by caregiver).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Associations between frailty, biomarkers of cerebral pathology, cognitive and neuropsychiatric symptoms: a memory clinic study.
Gilles V, Flaus A, Teillac A, Verny M, et al · · 2026 · PMID 41880327 · DOI 10.1016/j.tjfa.2026.100148
Verify or expand the search:
- PubMed search for NCT05254873
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Long term follow-up
Trials testing the same drug.
- NCT07150676 — Harmonized Clinical and Biological Database for Integrated Research Into the Management of Pediatric Acute Myeloid Leuke · not yet recruiting
- NCT05256459 — Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma · unknown
- NCT03022461 — HeartMate 3 CE Mark Study Long Term Follow-up · completed
Other Association de Recherche Bibliographique pour les Neurosciences trials
Trials by the same sponsor.
- NCT05385601 — Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography and Correlation to Imaging Data in · completed
- NCT05267028 — Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease · completed
- NCT05211752 — Eye Movements Recording Using a Mobile : Comparison to Standard Video-oculography in Young Athletes · completed
- NCT04730167 — The Monaco Initiative for Concussion in Motorsport Pilots · completed
- NCT04702763 — Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography in Patients With Multiple Sclerosis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05254873 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Association de Recherche Bibliographique pour les Neurosciences
- Last refreshed: 15 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05254873.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing